Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1

Author:

Dupuis Hippolyte12ORCID,Chevalier Benjamin123,Cardot-Bauters Catherine1,Jannin Arnaud124,Do Cao Christine1,Ladsous Miriam1,Cortet Christine1,Merlen Emilie1,Drouard Magali5,Aubert Sébastien6,Vidaud Dominique7,Espiard Stéphanie128,Vantyghem Marie-Christine128ORCID

Affiliation:

1. Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France

2. University of Lille , F-59000 Lille , France

3. Department of Nuclear Medicine, Huriez Hospital, Lille University Hospital , F-59000 Lille , France

4. Canther Laboratory U1277 Inserm—Team “Mucins, Cancer and drug resistance” team, Oncolille Institute , F-59000 Lille , France

5. Department of Dermatology, Huriez Hospital, Lille University Hospital , F-59000 Lille , France

6. Department of Pathology, Lille University Hospital , F-59000 Lille , France

7. Department of Genetic Medicine of System and Organ Diseases, Cochin Hospital, Federation of Genomic Medicine, Assistance Publique—Hôpitaux de Paris, AP-HP, Paris University Center , F-75014 Paris , France

8. Inserm U1190, Lille University, European Genomic Institute for Diabetes , F-59000 Lille , France

Abstract

Abstract Context In patients with neurofibromatosis type 1 (NF1), guidelines suggest screening for pheochromocytoma by metanephrine measurement and abdominal imaging, which may lead to the discovery of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and their differential diagnosis, gastrointestinal stromal tumors (GISTs). Other endocrine manifestations such as follicular thyroid carcinoma and primary hyperparathyroidism have also been reported in a few cases. Objective This study aimed to describe prevalence and clinical presentation of these manifestations through systematic screening in a large cohort of patients. Methods In this monocentric retrospective study, 108 patients with NF1 were included and screened for endocrine manifestations and GISTs. Clinical, laboratory, molecular profile, pathology, and morphologic (abdominal computed tomography scan and/or magnetic resonance imaging) and functional imaging were collected. Results Twenty-four patients (22.2% of the cohort, 16 female, mean age 42.6 years) presented with pheochromocytomas that were unilateral in 65.5%, benign in 89.7%, and with a ganglioneural component in 20.7%. Three female patients (2.8% of the cohort, aged 42-63 years) presented with well-differentiated GEP-NETs, and 4 (3.7%) with GISTs. One patient had primary hyperparathyroidism, 1 patient had medullary microcarcinoma, and 16 patients had goiter, multinodular in 10 cases. There was no correlation between pheochromocytoma and other NF1 tumoral manifestations, nor correlations between pheochromocytoma and NF1 genotype, despite a familial clustering in one-third of patients. Conclusion The pheochromocytoma prevalence in this NF1 cohort was higher (>20%) than previously described, confirming the interest of systematic screening, especially in young women. The prevalence of GEP-NETs and GISTs was about 3%, respectively. No phenotype–genotype correlation was observed.

Funder

Lille University hospital

Publisher

The Endocrine Society

Subject

Endocrinology, Diabetes and Metabolism

Reference42 articles.

1. Neurofibromatosis type 1 revisited;Williams;Pediatrics,2009

2. Identification of the neurofibromatosis type 1 gene product;Gutmann;Proc Natl Acad Sci U S A,1991

3. The neurofibromatosis type 1 gene encodes a protein related to GAP;Xu;Cell,1990

4. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors;Dasgupta;Cancer Res,2005

5. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference;Arch Neurol,1988

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3